Amgen’s decision to locate – and now expand – in Holly Springs fortifies the town’s and state’s reputations as ...

Atlantic Fish, an emerging Raleigh company developing cultivated seafood, has received a $50,000 SEED grant from North ...

Join Women in Bio's RTP Chapter on December 10 for its End-of-Year Celebration—a special evening for women to connect, celebrate achievements, and enjoy meaningful networking. Additionally, Pepper ...

Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.

In this interactive workshop, designed for small business owners and managers, you’ll discover key drivers of employee engagement, learn cost-effective strategies, and create a personalized engagement ...

Durham-based CytexOrtho, a company working to advance orthopedic joint preservation, has received approval from the U.S. Food and Drug Administration (FDA) to begin a first-in-human clinical study to ...

If you’re a visionary leader at a growth stage biopharma company, I help you identify a calculated and informed path to scale — one that mitigates risk, maximizes value, and capitalizes on your ...

The Conference Center at NCBiotech will be closed on Nov. 27, 2024. Also, NCBiotech's offices will be closed on Nov. 28-29, 2024, for the Thanksgiving holiday.

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...